Editorial
Published on 07 Nov 2023
Editorial: Understanding leukemia biology using genome editing techniques
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1323584
- 799 views
Type at least 3 characters
1,687 articles
Articles
Review
Published on 07 Nov 2023
Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1273305
- 2,067 views
- 2 citations
Original Research
Published on 07 Nov 2023
Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1256054
- 1,222 views
Case Report
Published on 03 Nov 2023
Case report: Deep molecular remissions post two separate CD19-targeted chimeric antigen receptor T-cell therapies do not prevent disease from relapsing in Philadelphia chromosome-positive acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1251738
- 1,130 views
Original Research
Published on 02 Nov 2023
Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1197340
- 2,054 views
- 2 citations
Case Report
Published on 01 Nov 2023
An adolescent with primary cutaneous follicle center lymphoma: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1273719
- 893 views
Case Report
Published on 01 Nov 2023
Case Report: A novel FGFR1 fusion in acute B-lymphoblastic leukemia identified by RNA sequencing
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1276695
- 1,168 views
- 1 citation
Original Research
Published on 01 Nov 2023
Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1272072
- 1,402 views
- 1 citation
Original Research
Published on 30 Oct 2023
Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1221414
- 1,025 views
Original Research
Published on 25 Oct 2023
Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1209110
- 1,789 views
Original Research
Published on 25 Oct 2023
Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1221471
- 2,633 views
- 1 citation
Original Research
Published on 24 Oct 2023
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1277453
- 3,782 views
- 5 citations
Original Research
Published on 24 Oct 2023
Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1264723
- 2,016 views
Case Report
Published on 24 Oct 2023
The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1228481
- 3,216 views
- 2 citations
Addendum
Published on 20 Oct 2023
Addendum: B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1267904
- 2,734 views
Case Report
Published on 20 Oct 2023
Case Report: Treatment of the rare B-cell lymphoblastic lymphoma with scalp lesion using rotation flap
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1252512
- 1,874 views